DUBLIN--(BUSINESS WIRE)--The "Noninvasive Cancer Diagnostics: Technologies and Global Markets" report has been added to Research and Markets' offering. The global market for non-invasive cancer diagnostics was valued at $107.4 billion in 2016 This market is estimated to grow from nearly $114.6 billion in 2017 to $159.8 billion by 2022 with a compound annual growth rate (CAGR) of 6.9% for the period of 2017-2022. The aim of this report is to initially conduct a review of the non-invasive cancer